Abstract
CRA is common among premenopausal women with early BC and may determine substantial impact on post-CT QOL. We examined factors associated with CRA in a modern cohort of patients receiving current standard (neo)adjuvant CT regimens (anthracycline [A]- and taxane [T]-based) and the relationship between CRA and long-term QOL.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have